A phase II study of sirolimus, tacrolimus, and rabbit anti-thymocyte globulin as graft-versus-host prophylaxis after unrelated-donor peripheral blood stem cell transplant

por Khaled, Samer K., Palmer, Joycelynne, StillerMS, Tracey, Senitzer, David, Maegawa, Rodrigo, Rodriguez, Roberto, Parker, Pablo M., Nademanee, Auayporn, Cai, Ji-Lian, Snyder, David S., Karanes, Chatchada, Osorio, Edna, Thomas, Sandra H., Forman, Stephen J., Nakamura, Ryotaro
Publicado 2012

Cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic hematopoietic stem cell transplantation: viremia, immunogenicity and survival outcom...

por Nakamura, Ryotaro, La Rosa, Corinna, Longmate, Jeffrey, Drake, Jennifer, Slape, Cynthia, Zhou, Qiao, Lampa, Melanie G., O'Donnell, Margaret, Cai, Ji-Lian, Farol, Len, Salhotra, Amandeep, Snyder, David S., Aldoss, Ibrahim, Forman, Stephen J., Miller, Jeffrey S., Zaia, John A., Diamond, Don J.
Publicado 2015

Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study

por Ali, Haris, Tsai, Ni-Chun, Synold, Timothy, Mokhtari, Sally, Tsia, Weimin, Palmer, Joycelynne, Stiller, Tracey, Al Malki, Monzr, Aldoss, Ibrahim, Salhotra, Amandeep, Rahmanuddin, Syed, Pullarkat, Vinod, Cai, Ji-Lian, Stein, Anthony, Forman, Stephen J., Marcucci, Guido, Mei, Matthew, Snyder, David S., Nakamura, Ryotaro
Publicado 2022

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantati...

por Chen, Robert W., Palmer, Joycelynne M., Tomassetti, Sarah, Popplewell, Leslie L., Alluin, Jessica, Chomchan, Pritsana, Nademanee, Auayporn P., Siddiqi, Tanya, Tsai, Ni-Chun, Chen, Lu, Zuo, Fay, Abary, Rosemarie, Cai, Ji-lian, Herrera, Alex F., Rossi, John J., Rosen, Steven T., Forman, Stephen J., Kwak, Larry W., Holmberg, Leona A.
Publicado 2018